The Fabrazyme® and Arbs and ACE Inhibitor Treatment (FAACET) Study

Clinical trial NCT00446862 · COMPLETED

Trial details

NCT number: NCT00446862
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Study type: OBSERVATIONAL

Fabry Disease Proteinuria

Start date: 2007-03-01
Primary completion: 2012-06-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.